140 related articles for article (PubMed ID: 35770425)
1. Changes in the Street Prices of Prescription Opioids During the COVID-19 Pandemic.
Mutter R; Black J; Iwanicki J
Psychiatr Serv; 2023 Jan; 74(1):63-65. PubMed ID: 35770425
[TBL] [Abstract][Full Text] [Related]
2. Crowdsourcing black market prices for prescription opioids.
Dasgupta N; Freifeld C; Brownstein JS; Menone CM; Surratt HL; Poppish L; Green JL; Lavonas EJ; Dart RC
J Med Internet Res; 2013 Aug; 15(8):e178. PubMed ID: 23956042
[TBL] [Abstract][Full Text] [Related]
3. Scoring the best deal: Quantity discounts and street price variation of diverted oxycodone and oxymorphone.
Lebin JA; Murphy DL; Severtson SG; Bau GE; Dasgupta N; Dart RC
Pharmacoepidemiol Drug Saf; 2019 Jan; 28(1):25-30. PubMed ID: 29766592
[TBL] [Abstract][Full Text] [Related]
4. Prescribing of Opioid Analgesics and Buprenorphine for Opioid Use Disorder During the COVID-19 Pandemic.
Currie JM; Schnell MK; Schwandt H; Zhang J
JAMA Netw Open; 2021 Apr; 4(4):e216147. PubMed ID: 33856474
[TBL] [Abstract][Full Text] [Related]
5. Fourth Wave of Opioid (Illicit Drug) Overdose Deaths and Diminishing Access to Prescription Opioids and Interventional Techniques: Cause and Effect.
Manchikanti L; Singh VM; Staats PS; Trescot AM; Prunskis J; Knezevic NN; Soin A; Kaye AD; Atluri S; Boswell MV; Abd-Elsayed A; Hirsch JA
Pain Physician; 2022 Mar; 25(2):97-124. PubMed ID: 35322965
[TBL] [Abstract][Full Text] [Related]
6. Comparison of Postpartum Opioid Prescriptions Before vs During the COVID-19 Pandemic.
Steuart SR; Lawler EC; Bagwell Adams G; Shone H; Abraham AJ
JAMA Netw Open; 2023 Apr; 6(4):e236438. PubMed ID: 37010867
[TBL] [Abstract][Full Text] [Related]
7. Diversion and Illicit Sale of Extended Release Tapentadol in the United States.
Dart RC; Surratt HL; Le Lait MC; Stivers Y; Bebarta VS; Freifeld CC; Brownstein JS; Burke JJ; Kurtz SP; Dasgupta N
Pain Med; 2016 Aug; 17(8):1490-6. PubMed ID: 26814267
[TBL] [Abstract][Full Text] [Related]
8. Web-Based Discussion and Illicit Street Sales of Tapentadol and Oxycodone in Australia: Epidemiological Surveillance Study.
Black J; Margolin ZR; Bau G; Olson R; Iwanicki JL; Dart RC
JMIR Public Health Surveill; 2021 Dec; 7(12):e29187. PubMed ID: 34932012
[TBL] [Abstract][Full Text] [Related]
9. Comparative Rates of Mortality and Serious Adverse Effects Among Commonly Prescribed Opioid Analgesics.
Murphy DL; Lebin JA; Severtson SG; Olsen HA; Dasgupta N; Dart RC
Drug Saf; 2018 Aug; 41(8):787-795. PubMed ID: 29582394
[TBL] [Abstract][Full Text] [Related]
10. The effect of the COVID-19 pandemic on the prescribing of opioid and opioid use disorder medications within an academic medical center in California.
Fstkchian AK; Koch J; Bahjri K; Hong LT
Front Public Health; 2023; 11():1105681. PubMed ID: 37351093
[TBL] [Abstract][Full Text] [Related]
11. The development of a comprehensive risk-management program for prescription opioid analgesics: researched abuse, diversion and addiction-related surveillance (RADARS).
Cicero TJ; Dart RC; Inciardi JA; Woody GE; Schnoll S; Muñoz A
Pain Med; 2007 Mar; 8(2):157-70. PubMed ID: 17305687
[TBL] [Abstract][Full Text] [Related]
12. Trends in abuse of Oxycontin and other opioid analgesics in the United States: 2002-2004.
Cicero TJ; Inciardi JA; Muñoz A
J Pain; 2005 Oct; 6(10):662-72. PubMed ID: 16202959
[TBL] [Abstract][Full Text] [Related]
13. Characteristics of Prescription Opioid Analgesics in Pregnancy and Risk of Neonatal Opioid Withdrawal Syndrome in Newborns.
Esposito DB; Huybrechts KF; Werler MM; Straub L; Hernández-Díaz S; Mogun H; Bateman BT
JAMA Netw Open; 2022 Aug; 5(8):e2228588. PubMed ID: 36001312
[TBL] [Abstract][Full Text] [Related]
14. Trends in opioid analgesic abuse and mortality in the United States.
Dart RC; Surratt HL; Cicero TJ; Parrino MW; Severtson SG; Bucher-Bartelson B; Green JL
N Engl J Med; 2015 Jan; 372(3):241-8. PubMed ID: 25587948
[TBL] [Abstract][Full Text] [Related]
15. The relative abuse liability of oral oxycodone, hydrocodone and hydromorphone assessed in prescription opioid abusers.
Walsh SL; Nuzzo PA; Lofwall MR; Holtman JR
Drug Alcohol Depend; 2008 Dec; 98(3):191-202. PubMed ID: 18606504
[TBL] [Abstract][Full Text] [Related]
16. Concerns among people who use opioids during the COVID-19 pandemic: a natural language processing analysis of social media posts.
Sarker A; Nataraj N; Siu W; Li S; Jones CM; Sumner SA
Subst Abuse Treat Prev Policy; 2022 Mar; 17(1):16. PubMed ID: 35248103
[TBL] [Abstract][Full Text] [Related]
17. Postmarketing Analysis of Misuse, Abuse, and Diversion of Xtampza ER.
Geoffrey Severtson S; Kreider SED; Amioka EC; Margolin ZR; Iwanicki JL; Dart RC
Pain Med; 2020 Dec; 21(12):3660-3668. PubMed ID: 33094329
[TBL] [Abstract][Full Text] [Related]
18. Prescription opioid abuse among drug-involved street-based sex workers.
Surratt HL; Inciardi JA; Kurtz SP
J Opioid Manag; 2006; 2(5):283-9. PubMed ID: 17319260
[TBL] [Abstract][Full Text] [Related]
19. Misuse of Prescription and Illicit Drugs in Middle Adulthood in the Context of the Opioid Epidemic.
Faller RW; Erausquin JT; McCoy TP
Subst Use Misuse; 2021; 56(2):333-337. PubMed ID: 33325317
[No Abstract] [Full Text] [Related]
20. Prescription opioid abuse and diversion in an urban community: the results of an ultrarapid assessment.
Inciardi JA; Surratt HL; Cicero TJ; Beard RA
Pain Med; 2009 Apr; 10(3):537-48. PubMed ID: 19416440
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
